How kissing can actually spread depression and anxiety: study
We all know that kissing and other close contact can transmit infections like the common cold, mononucleosis and herpes.
A new study out of Iran suggests that depression and anxiety might be transmissible through kissing, too.
3 A new study out of Iran suggests that depression and anxiety might be transmissible through kissing.
Photographee.eu – stock.adobe.com
Depression and anxiety can trigger the release of the stress hormone cortisol, which can disrupt the delicate balance of bacteria in the mouth.
Spouses can transfer this bacteria while smooching — in fact, prior research found that as many as 80 million bacteria are transferred in just one 10-second kiss.
The authors of the new study found that when one spouse had poor mental health and trouble sleeping, the healthy partner suffered similar symptoms after just six months. Bacteria were to blame.
'Specifically, in couples where one partner had [depression/anxiety], the oral microbiota of the healthy spouse mirrored that of the affected partner,' the researchers wrote in the Exploratory Research and Hypothesis in Medicine journal.
3 Depression and anxiety can trigger the release of the stress hormone cortisol, which can disrupt the delicate balance of bacteria in the mouth.
Tinnakorn – stock.adobe.com
The team followed 268 newlywed Iranian couples. One set of the honeymooners reported struggling with depression, anxiety and sleep problems while their spouses were healthy at the start of the study.
Participants completed surveys about their mental health and provided saliva samples for cortisol measurement and oral bacteria swabs for DNA analysis.
The researchers reported that the healthy spouses, particularly women, had significant increases in depression, anxiety and sleep difficulties after six months. These symptoms were not as intense as their partners'.
Four types of bacteria — Clostridia, Veillonella, Bacillus and Lachnospiraceae — were relatively abundant in the samples. Some species of these bacteria may be harmful to health.
3 Prior research found that as many as 80 million bacteria are transferred in just one 10-second kiss.
Alessandro Grandini – stock.adobe.com
The researchers acknowledged several limitations to the study, including not taking into account underlying health issues and dietary factors that may influence oral bacteria.
They suggest exploring whether bacteria play a role in other mental and brain-related conditions.
Therapists and researchers have long recognized that a person's mental health struggles can have a 'ripple effect' on loved ones. This new study suggests that this impact is fueled in part by harmful mouth bacteria.
Studies have identified other ways couples can be in sync. Their heart rates, sleep patterns and even their stress and reproductive hormones can synchronize over time.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
10-08-2025
- New York Post
Iran sends surviving nuclear scientists into hiding after 14 killed in Israeli strikes, report says
Iran has sent its remaining nuclear scientists deep into hiding after the 12-day conflict in June that saw at least 14 killed by Israeli strikes, according to a new report. The more than 15 top scientists who survived the attack have left their homes and universities to hide in secure locations in Tehran or along the northern coast, a senior Iranian official told The Telegraph. But Israeli experts warned that whoever stands poised to inherit the work of the slain scientists — no matter where they choose to hide — are already 'dead men walking,' according to the UK outlet. 3 Iran's Supreme Leader Ayatollah Ali Khamenei speaking at a mourning ceremony for Iranian military leaders and scientists that were killed during the war with Israel in Tehran on July 29, 2025. via REUTERS 'Those who are left will be at the forefront of any Iranian attempt to reach a nuclear bomb, hence they will automatically become targets for Israel as Israel has shown in the past,' said Danny Citrinowicz, the former head of the Iranian strategic desk in Israeli Defense Intelligence agency. 'I have no doubt about it. Any scientist that deals with the nuclear issue will be eliminated or will be threatened with elimination,' he said. Israel has allegedly put together a total list of about 100 Iranian scientists who may be future targets to halt Tehran's nuclear ambition, according to the Telegraph. At least 14 of Tehran's top atomic experts were killed during Iran's 12-day war with Israel for their alleged personal role in developing highly enriched uranium, which the Jewish state maintains would be used for a nuclear weapon. 3 Smoke rising from an Israeli strike in Tehran on June 16, 2025. PhotoAmong them were Fereidoun Abbasi, a former head of Iran's Atomic Energy Organization, and Mohammad Mehdi Tehranchi, head of the Islamic Azad University in Tehran. The deadly strikes prompted Tehran to issue the new security measures for its surviving leading scientists, the Iranian official told The Telegraph. Iran also has reportedly replaced its atomic experts teaching in colleges 'with people who have no connection with the nuclear program.' Universities where some of the targets worked were hit and damaged by Israeli airstrikes during the war. 3 A residential building in Tehran destroyed in an Israeli strike seen on June 29, 2025. Footage byThe report of Tehran's efforts to bolster security for its scientists comes just days after Iran convicted and executed Rouzbeh Vadi, a reactor engineer accused of spying for Israel and helping facilitate the attack on his colleagues. Iran has undertaken a massive espionage crackdown after the war, arresting hundreds of people across the country and expelling more than a million Afghani refugees branded as possible spies for Israel. Hostage Air Worldwide, a nonprofit that works to help political captives and their families, said that at least four Iranian-Americans are among the hundreds detained in the espionage raids.
Fox News
06-08-2025
- Fox News
Russia and China tick Doomsday Clock toward midnight as Hiroshima bombing hits 80 years
Wednesday marks the 80th anniversary of when the U.S. employed the first ever nuclear bomb over the Japanese city of Hiroshima, followed by the bombing of Nagasaki three days later on Aug. 9. But despite nearly a century of lessons learned, nuclear warfare still remains a significant threat. "This is the first time that the United States is facing down two nuclear peer adversaries – Russia and China," Rebeccah Heinrichs, nuclear expert and senior fellow at the Hudson Institute, told Fox News Digital. Heinrichs explained that not only are Moscow and Beijing continuing to develop new nuclear capabilities and delivery systems, but they are increasingly collaborating with one another in direct opposition to the West, and more pointedly, the U.S. "It's a much more complex nuclear threat environment than what the United States even had to contend with during the Cold War, where we just had one nuclear peer adversary in the Soviet Union," she said. "In that regard, it's a serious problem, especially when both China and Russia are investing in nuclear capabilities and at the same time have revanchist goals." Despite the known immense devastation that would accompany an atomic war between two nuclear nations, concern has been growing that the threat of nuclear war is on the rise. The bombings of Hiroshima and Nagasaki – which collectively killed some 200,000 people, not including the dozens of thousands who later died from radiation poisoning and cancer – have been attributed with bringing an end to World War II. But the bombs did more than end the deadliest war in human history – they forever changed military doctrine, sparked a nuclear arms race and cemented the concept of deterrence through the theory of mutually assured destruction. Earlier this year the Bulletin of Atomic Scientists moved forward the "Doomsday Clock" by one second – pushing it closer to "midnight," or atomic meltdown, than ever before. In January, the board of scientists and security officials in charge of the 78-year-old clock, which is used to measure the threat level of nuclear warfare, said that moving the clock to 89 seconds to midnight "signals that the world is on a course of unprecedented risk, and that continuing on the current path is a form of madness." Despite the escalated nuclear threats coming out of North Korea, and international concern over the Iranian nuclear program, the threat level largely came down to the three biggest players in the nuclear arena: Russia, the U.S. and China. The increased threat level was attributed to Russia's refusal to comply with international nuclear treaties amid its continuously escalating war in Ukraine and its hostile opposition to NATO nations, as well as China's insistence on expanding its nuclear arsenal. But the Bulletin, which was founded by scientists on the Manhattan Project in 1945 to inform the public of the dangers of atomic warfare, also said the U.S. has a role in the increased nuclear threat level. "The U.S. has abdicated its role as a voice of caution. It seems inclined to expand its nuclear arsenal and adopt a posture that reinforces the belief that 'limited' use of nuclear weapons can be managed," the Bulletin said. "Such misplaced confidence could have us stumble into a nuclear war." But Heinrichs countered the "alarmist" message and argued that deterrence remains a very real protectant against nuclear warfare, even as Russia increasingly threatens Western nations with atomic use. "I do think that it's a serious threat. I don't think it's inevitable that we're sort of staring down nuclear Armageddon," she said. Heinrichs argued the chief threat is not the number of nuclear warheads a nation possesses, but in how they threaten to employ their capabilities. "I think that whenever there is a threat of nuclear use, it's because adversaries, authoritarian countries, in particular Russia, is threatening to use nuclear weapons to invade another country. And that's where the greatest risk of deterrence failure is," she said. "It's not because of the sheer number of nuclear weapons." Heinrichs said Russia is lowering the nuclear threshold by routinely threatening to employ nuclear weapons in a move to coerce Western nations to capitulate to their demands, as in the case of capturing territory in Ukraine and attempting to deny it NATO access. Instead, she argued that the U.S. and its allies need to improve their deterrence by not only staying on top of their capabilities but expanding their nuclear reach in regions like the Indo-Pacific. "The answer is not to be so afraid of it or alarmed that you capitulate, because you're only going to beget more nuclear coercion if you do that," she said. "The answer is to prudently, carefully communicate to the Russians they are not going to succeed through nuclear coercion, that the United States also has credible response options. "We also have nuclear weapons, and we have credible and proportional responses, and so they shouldn't go down that path," Heinrichs said. "That's how we maintain the nuclear peace. That's how we deter conflict. And that's how we ensure that a nuclear weapon is not used."
Yahoo
30-07-2025
- Yahoo
Wegovy maker Novo's profit warning triggers $70 billion share rout
By Jacob Gronholt-Pedersen, Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) -Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the obesity drug market. Novo named Maziar Mike Doustdar as its new chief executive, turning to a veteran insider to revive sales and reassure investors rattled by fears the Danish drugmaker is losing ground in the obesity drug race it started. Doustdar's appointment failed to stem a stock market rout sparked by Novo slashing its outlook for 2025 sales growth to between 8% and 14%, from between 13% and 21% previously. Its shares plunged nearly 30% before paring some losses to trade down over 20% by mid-afternoon. The shares are now down 44% this year. "The magnitude of the guidance cut is a shocker," Markus Manns, a portfolio manager at mutual fund firm Union Investment, a Novo shareholder, told Reuters, adding that Novo's issues went deeper than "compounded" copycats to Wegovy. Compounded drugs are custom-made medicines that are based on the same ingredients as branded drugs. Novo has been hit by copycats of its GLP-1 drugs Wegovy for weight-loss and Ozempic for diabetes. U.S. law bars pharmacies from replicating approved drugs, but has allowed 'compounding' for patients needing custom doses or formulations. The company said in a statement that it cut its 2025 sales outlook due to lower growth expectations in the second half in the U.S., both for Wegovy and Ozempic in the GLP-1 diabetes market. The drugmaker, which became Europe's most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as it looks to turn things around after the abrupt removal in May of CEO Lars Fruergaard Jorgensen. At its peak in June 2024, Novo was worth as much as $615 billion, but its shares have plunged on investor concerns about the company's experimental drug pipeline and its ability to navigate challenges in the U.S. market. "The stock has gone from being a market darling to one of its biggest letdowns," said Angelo Meda, portfolio manager and head of equities at Banor SIM in Milan, which has a small Novo stake. "The biggest concern is the illegal channel siphoning away market share - something that's hard to quantify. Rebuilding trust will take time." NEW CEO AN INSIDER Doustdar, an Iranian-born, Austrian national, who grew up in the United States, joined Novo in 1992 and will take on the new role on August 7. He currently serves as vice president for international operations, a role he took after leading the company's businesses first in the Middle East and then in Southeast Asia, Novo said. "We need to increase the sense of urgency and execute differently," Doustdar told investors and analysts on a call. "The fact that my announcement comes right after the guidance update, just makes the mandate ahead even more clear." Some analysts and investors had argued that Novo should select an American, or a person with extensive experience working in the United States as its next CEO. Novo has lost its first-mover advantage in the United States this year to U.S. rival Eli Lilly. The new chief executive's most urgent challenge, according to investors and analysts, is to revive Novo's performance in the United States, the largest market by far for weight-loss drugs and where they are most profitable. Novo launched its weight-loss drug Wegovy nearly two and a half years before Eli Lilly's Zepbound. But Zepbound prescriptions surpassed those of Wegovy this year by more than 100,000 a week. In May, Novo said it expected many of the roughly one million U.S. patients using compounded GLP-1 drugs to switch to branded treatments after a U.S. Food and Drug Administration ban on compounded copies of Wegovy took effect on May 22. "Unfortunately, our latest market research indicates that has not happened," Chief Financial Officer Karsten Munk Knudsen said on a call with analysts on Tuesday. One million or more U.S. patients are still using compounded GLP-1s, he said. Novo has stepped up its dialogue with the U.S. FDA to limit unlawful compounding of its drugs, the head of U.S. operations David Moore added on the call. "Compounding continues to be an issue that we have to address," Moore said. ($1 = 0.8672 euros) Sign in to access your portfolio
